{"denoms":[{"counts":[{"groupId":"BG000","value":"81"}],"units":"Participants"}],"groups":[{"description":"MOR00208:\n\nMOR00208 was administered via IV infusion at a dose of 12 mg/kg. For the first three cycles (Cycles 1 to 3) of the study each cycle consisted of a MOR00208 infusion on Day 1, Day 8, Day 15 and Day 22 of the cycle. Additionally, a loading dose was administered on Day 4 of Cycle 1. Thereafter MOR00208 was administered on a bi-weekly (every 14 days) basis with infusions on Day 1 and Day 15 of each 28-day cycle.\n\nLEN:\n\nParticipants self-administered a starting dose of 25 mg oral LEN daily on Days 1-21 of each cycle, for up to 12 cycles in total. LEN dose could be modified in a de-escalating fashion or discontinued based upon clinical and laboratory findings. On days when both study drugs were given together, LEN was administered prior to MOR00208.","id":"BG000","title":"Treatment (MOR00208, Lenalidomide)"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"}],"title":"<=18 years"},{"measurements":[{"groupId":"BG000","value":"23"}],"title":"Between 18 and 65 years"},{"measurements":[{"groupId":"BG000","value":"58"}],"title":">=65 years"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Age, Categorical","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"9.53","value":"69.3"}]}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"37"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"44"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"}],"title":"American Indian or Alaska Native"},{"measurements":[{"groupId":"BG000","value":"2"}],"title":"Asian"},{"measurements":[{"groupId":"BG000","value":"0"}],"title":"Native Hawaiian or Other Pacific Islander"},{"measurements":[{"groupId":"BG000","value":"0"}],"title":"Black or African American"},{"measurements":[{"groupId":"BG000","value":"72"}],"title":"White"},{"measurements":[{"groupId":"BG000","value":"0"}],"title":"More than one race"},{"measurements":[{"groupId":"BG000","value":"7"}],"title":"Unknown or Not Reported"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Race (NIH/OMB)","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"7"}]}],"title":"Hungary"},{"categories":[{"measurements":[{"groupId":"BG000","value":"5"}]}],"title":"Belgium"},{"categories":[{"measurements":[{"groupId":"BG000","value":"6"}]}],"title":"United States"},{"categories":[{"measurements":[{"groupId":"BG000","value":"3"}]}],"title":"Czechia"},{"categories":[{"measurements":[{"groupId":"BG000","value":"7"}]}],"title":"Poland"},{"categories":[{"measurements":[{"groupId":"BG000","value":"13"}]}],"title":"Italy"},{"categories":[{"measurements":[{"groupId":"BG000","value":"5"}]}],"title":"United Kingdom"},{"categories":[{"measurements":[{"groupId":"BG000","value":"9"}]}],"title":"France"},{"categories":[{"measurements":[{"groupId":"BG000","value":"11"}]}],"title":"Germany"},{"categories":[{"measurements":[{"groupId":"BG000","value":"15"}]}],"title":"Spain"}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Region of Enrollment","unitOfMeasure":"Participants"}]}